Authors
Yizhuo Wang, Wei He, Xiaoyun Yang, Yang Zhang, Rong Xu, Yinchun Liu, Wenqian Lin, Qingsong Liu, Xiaoquan Yang
Published in
Analytical methods : advancing methods and applications. Oct 30, 2026. Epub Oct 30, 2026.
Abstract
Simultaneous detection of dual microRNA biomarkers is crucial for accurate prognosis and treatment monitoring of cervical spondylosis, yet remains challenging due to the lack of stringent logic control and high-fidelity signal amplification. Herein, we report an AND-gate-controlled colorimetric assay that integrates target-recycling strand displacement amplification, CRISPR/Cas13a/crRNA-mediated trans-cleavage, and self-priming cyclic amplification for sensitive and specific analysis of two cervical spondylosis-associated miRNAs (miRNA-221 and miRNA-146a). Only when both targets are present does the cascade proceed, producing double-stranded amplicons that trigger SYBR Green I-catalyzed TMB oxidation, yielding a naked-eye-visible blue signal. The assay exhibits a broad linear range from 10 fM to 500 pM, a detection limit of 2.12 fM, excellent selectivity, and good repeatability. Importantly, we applied this method to clinically evaluate the therapeutic effect of auricular point pressing (ear acupressure), a traditional Chinese medicine intervention for cervical spondylosis. In a 4-week study of 20 patients, the treatment group receiving auricular point pressing showed significant downregulation of both miRNAs compared to baseline, while the control group showed no notable change. Results correlated well with RT-qPCR, confirming reliability. This logic-controlled CRISPR/Cas13a platform offers a robust, equipment-free strategy for early prognosis of cervical spondylosis and objective monitoring of auricular point pressing therapy.
PMID:
42961320
Bibliographic data and abstract were imported from PubMed on 30 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0